H
Halton Pediatric Allergy | Burlington, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Enrolling
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
This clinical research study investigates the safety, tolerability and efficacy of a peanut SLIT-tablet in adults, adolescents, and children with pea...
Active, not recruiting
Peanut Allergy
Other: Placebo
Biological: Peanut SLIT-tablet
The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut a...
Enrolling
Peanut Allergy
Allergy
Combination Product: DBV712 250 mcg
Combination Product: Placebo
Trial sponsors
A
D
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems